MYD88 and psoriasis: Regarding the fundamental role of the TLR4-NF-κB pathway in the pathogenesis of psoriasis (148), Flii may interfere with the binding of TLR4 to myeloid differentiation primary response protein 88 (MyD88), which thereby inhibits the NF-κB pathway (149).